SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Geron (GERN)
An SI Board Since December 1996
Posts SubjectMarks Bans
50 2 0
Emcee:  Boyce Burge Type:  Unmoderated
Introduction Compact
Geron (GERN) is a telomere company, based in Menlo Park. Small market cap but lots of proprietary knowledge of telomeres and telomerase. Telomeres are the DNA bits on the ends of chromosomes that get shorter each time the cell divides. When it divides 50 times ...pffft, cell dies all on its own. Cancer cells turn on telomerase, add back the DNA bits, and obtain a sort of messy immortality, until the "host" dies.

Anyway, though GERN doesnt have an anti-telomerase molecule in clinical trials yet, it will be a barn burner if one is found. About 8 million shares outstanding, went public in July (bad timing) and it closed at 9 today. Comments, info, please.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
50 Contact information for Cryogenic Solutions is Cryogenic Solutions Inc Bus PhJ Curshen-8/28/1997
49 Anyone have an e-mail address or fax no for CYGS?James Reynolds-8/28/1997
48 Is there any reason why you are not looking at CYGS? They are in the same fielJ Curshen-8/27/1997
47 WSJ had brief article on Geron today, pointing out that the telomerase gene payBoyce Burge-8/27/1997
46 You guys are missing the boat in CYGS trading at $0.40J Curshen-8/19/1997
45 CYGS Cryogenic Solutions is an excellent sympathy play with GERON for Monday.J Curshen-8/18/1997
44 Good research. Your link did not take me directly to the story, so I am tryiDan Lisman-5/27/1997
43 Sorry can't get exact page, go to contents and Cancer testceleryroot.com-5/27/1997
42 From this weeks London Sunday Times: sunday-times.co.ukceleryroot.com-5/27/1997
41 Im so skeptical... that telomeres will make a dent in the cancer problem anytimBoyce Burge-5/27/1997
40 Walid, What does the SA article it say? Kafka666(no name provided)-5/22/1997
39 any bulls out there see article on telomeres in Scientific American . Ouch !!!walid moukarzel-5/22/1997
38 GERN followers: I'm starting to believe there might be real potential for louis mason-4/29/1997
37 What press release did you read? Paying 58m upfront? NO! A 10m equity investmenAndrew H-3/25/1997
36 *&^$$!! = Pharmacia While I agree that Geron's technology is very comtommysdad-3/24/1997
35 Buy this stock now! Stock waay undervalued especially in light of the new cancSniper-3/24/1997
34 Jerry, I've been following Geron from before it went public -- a friend pBulbaMan-3/10/1997
33 Stock is stablizing. How did you get into GERN? I subscribe to CSTL. David isjbershad-3/7/1997
32 Wish I knew why the stock was tanking. Could it be a delayed reaction to the BulbaMan-3/5/1997
31 Anybody know why below ten? Jerryjbershad-3/5/1997
30 Sorry, I meant to say Murphy's plug was in Worth not Business Week. BusinesBulbaMan-3/3/1997
29 Business Week, hey? Murphy is really getting around these days. The problem IAndrew H-3/1/1997
28 Louis, I don't think anyone has all the answers to your questions. What mBulbaMan-3/1/1997
27 Dear Marty, How broadly do you think that Geron's patent will be enforced louis mason-2/26/1997
26 Elizabeth Blackburn, quoted in the NY Times article, is on Geron's scienBulbaMan-2/26/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News